Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01770314 · ClinicalTrials.gov registry record · Phase 2

Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication.

A Phase 2 study of Medication Adherence, sponsored by Inflexxion.

Completed
Registry status
Phase 2
Development phase
176
Enrollment target
1
Study location

NCT01770314: Completed Phase 2 study of Medication Adherence, sponsored by Inflexxion.

NCT01770314 is a Phase 2 study of Medication Adherence that has completed, run by Inflexxion. The registered enrollment target is 176 participants, below the 1,653-participant average among 52 other Medication Adherence trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01770314, a Phase 2 study of Medication Adherence, has completed, sponsored by Inflexxion.

COMPLETED
Registry status
Phase 2
Development phase
176 participants
Enrollment target
1
Study location

Study Summary

The purpose of this project is to test whether an online pain medication intervention is a feasible and effective way to increase opioid pain medication safety.

Primary Outcome

Responses are measured on a 4-point Likert scale (1= "Not at all confident" and 4= "Extremely confident"). The total Score range:8=least confident, 32=most confident. How confident do you feel in your ability to do each of the following activities, today? 1. I can recognize side effects that are related to my opioid medicine. 2. I can avoid giving my opioid medicine to someone else. Etc.. 1 - Not at all confident 2 - Somewhat confident 3 - Very confident 4 - Extremely confident Items have been

Conditions Studied

Interventions

  • BEHAVIORAL Experimental

Study Locations (1)

Massachusetts

  • Inflexxion Inc - Newton

Trial Details

FieldValue
Enrollment Target 176 participants
Start Date 2012-09
Est. Completion 2013-09
Phase Phase 2
Inflexxion

7 total trials

What the finished NCT01770314 record still lists

NCT01770314 is an interventional study that assigns participants to a tested intervention. The registered 176 participants enrollment target is mid-sized for trials with a published cap, below the 1,653-participant average among 52 other Medication Adherence trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Medication Adherence appearing as the primary indexed condition, and to 1 intervention - of which Experimental is the first listed.

NCT01770314 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01770314 about?

NCT01770314 is a clinical study titled "Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication.". The purpose of this project is to test whether an online pain medication intervention is a feasible and effective way to increase opioid pain medication safety.

What is the current status of trial NCT01770314?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 176 participants. The study started on 2012-09. Estimated completion is 2013-09.

What conditions does trial NCT01770314 study?

This clinical trial studies the following conditions: Medication Adherence.

What interventions are being tested in trial NCT01770314?

The interventions under investigation include: Experimental (BEHAVIORAL).

Who is sponsoring clinical trial NCT01770314?

This trial is sponsored by Inflexxion, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01770314 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Medication Adherence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01770314's enrollment target sits among peer trials

176 22nd of 52 higher than 31 of 52 other Medication Adherence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Medication Adherence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03304821 · 176 participants · Phase 2

    Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease

  • NCT03447938 · 176 participants · NA

    The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial

  • NCT03824145 · 176 participants · NA

    Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer

  • NCT04177914 · 176 participants · Phase 3

    HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01770314, the US trial registry maintained by the National Library of Medicine. NCT01770314 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.